Postarrest stalling rather than crawling favors CD8+ over CD4+ T-cell migration across the blood–brain barrier under flow in vitro

European Journal of Immunology

Volumn 46, Issue 9, 2016, Pages 2187-2203

  Rudolph, Henriette ^a   Klopstein, Armelle ^a   Gruber, Isabelle ^a   Blatti, Claudia ^a   Lyck, Ruth ^a   Engelhardt, Britta ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Adhesion; Blood brain barrier; Crawling; Diapedesis; Stalling; T cells

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; DIAPEDESIS; EXTRAVASATION; FLOW CYTOMETRY; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; IN VITRO STUDY; LYMPHOCYTE MIGRATION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 84985994414     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201546251     Document Type: Article

References (63)

1. Lassmann, H., Classification of demyelinating diseases at the interface between etiology and pathogenesis. Curr. Opin. Neurol. 2001. 14: 253–258.
2. Pierson, E., Simmons, S. B., Castelli, L. and Goverman, J. M., Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol. Rev. 2012. 248: 205–215.
3. Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T. et al., RORgt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011. 12: 560–567.
4. Friese, M. A., Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain 2005. 128: 1747–1763.
5. Liblau, R. S., Wong, F. S., Mars, L. T., Santamaria, P., Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity 2002. 17: 1–6.
6. Neumann, H., Medana, I. M., Bauer, J. and Lassmann, H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 2002. 25: 313–319.
7. Ifergan, I., Kebir, H., Alvarez, J. I., Marceau, G., Bernard, M., Bourbonniere, L., Poirier, J. et al., Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on 4 integrin. Brain 2011. 134: 3560–3577.
8. Lucchinetti, C. F., Popescu, B. F. G., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., Brück, W. et al., Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 2011. 365: 2188–2197.
9. Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M. et al., Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 2000. 192: 393–404.
10. Junker, A., Ivanidze, J., Malotka, J., Eiglmeier, I., Lassmann, H., Wekerle, H., Meinl, E. et al., Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 2007. 130: 2789–2799.
11. Jacobsen, M., Cepok, S., Quak, E., Happel, M., Gaber, R., Ziegler, A., Schock, S. et al., Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 2002. 125: 538–550.
12. Fugger, L., Friese, M. A. and Bell, J. I., From genes to function: the next challenge to understanding multiple sclerosis. Nat. Rev. Immunol. 2009. 9: 408–417.
13. Mars, L. T., Saikali, P., Liblau, R. S., Arbour, N., Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. Biochim. Biophys. Acta 2011. 1812: 151–161.
14. Brynedal, B., Duvefelt, K., Jonasdottir, G., Roos, I. M., Åkesson, E., Palmgren, J. and Hillert, J., HLA-A confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis. PLoS One 2007. 2: e664.
15. Burfoot, R. K., Jensen, C. J., Field, J., Stankovich, J., Varney, M. D., Johnson, L. J., Butzkueven, H. et al., SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens 2008. 71: 42-50.
16. Engelhardt, B., Sorokin, L., The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction. Semin. Immunopathol. 2009. 31: 497–511.
17. Engelhardt, B., Ransohoff, R. M., Capture, crawl, cross: the T cell code to breach the blood–brain barriers. Trends Immunol. 2012. 33: 579–589.
18. Ransohoff, R. M. and Engelhardt, B., The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 2012. 12: 623–635.
19. Lyck, R., Engelhardt, B., Going against the tide - how encephalitogenic T cells breach the blood-brain barrier. J. Vasc. Res. 2012. 49: 497–509.
20. Sallusto, F., Impellizzieri, D., Basso, C., Laroni, A., Uccelli, A., Lanzavecchia, A. and Engelhardt, B., T-cell trafficking in the central nervous system. Immunol. Rev. 2012. 248: 216–227.
21. Coles, A. J., Fox, E., Vladic, A., Gazda, S. K., Brinar, V., Selmaj, K. W., Bass, A. D.-D. et al., Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes. Lancet Neurol. 2011. 10: 338–348.
22. Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P. A., Libonati, M. A., Willmer-Hulme, A. J. et al., A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 2003. 348: 15–23.
23. Steiner, O., Coisne, C., Cecchelli, R., Boscacci, R., Deutsch, U., Engelhardt, B., Lyck, R., Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium. J. Immunol. 2010. 185: 4846–4855.
24. Coisne, C., Lyck, R., Engelhardt, B., Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo. Fluids Barriers CNS 2013. 10: 7.
25. Gorina, R., Lyck, R., Vestweber, D., Engelhardt, B., β2 Integrin−mediated crawling on endothelial ICAM-1 and ICAM-2 is a prerequisite for transcellular neutrophil diapedesis across the inflamed blood−brain barrier. J. Immunol. 2013. 192: 324–337.
26. Abadier, M., Jahromi, N. H., Cardoso-Alves, L., Boscacci, R., Vestweber, D., Barnum, S., Deutsch, U. et al., Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier. Eur. J. Immunol. 2015. 45: 1043-58
27. Bauer, M., Brakebusch, C., Coisne, C., Sixt, M., Wekerle, H., Engelhardt, B., Fässler, R., beta1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity. Proc. Natl. Acad. Sci. U S A 2009. 106: 1920–1925.
28. Zehn, D., Lee, S. Y., Bevan, M. J., Complete but curtailed T-cell response to very low-affinity antigen. Nature 2009. 458: 211–214.
29. Moreau, H. D., Lemaître, F., Terriac, E., Azar, G., Piel, M., Lennon-Dumenil, A.-M., Bousso, P., Dynamic in situ cytometry uncovers T cell receptor signaling during immunological synapses and kinapses in vivo. Immunity 2012. 37: 351–363.
30. Shulman, Z., Cohen, S. J., Roediger, B., Kalchenko, V., Jain, R., Grabovsky, V., Klein, E. et al., Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots. Nat. Immunol. 2011. 13: 67–76.
31. Ransohoff, R. M., PML risk and natalizumab: more questions than answers. Lancet Neurol. 2010. 9: 231–233.
32. Young, K. G., MacLean, S., Dudani, R., Krishnan, L., Sad, S., CD8+ T cells primed in the periphery provide time-bound immune-surveillance to the central nervous system. J. Immunol. 2011. 187: 1192–1200.
33. Bartholomaus, I., Kawakami, N., Odoardi, F., Schläger, C., Miljkovic, D., Ellwart, J. W., Klinkert, W. E. F. et al., Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009. 461: 94–98.
34. Vajkoczy, P., Laschinger, M., Engelhardt, B., α4-integrin-VCAM-1 binding mediates G protein–independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 2001. 108: 557–565.
35. Greenwood, J., Heasman, S. J., Alvarez, J. I., Prat, A., Lyck, R., Engelhardt, B., Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain. Neuropathol. Appl. Neurobiol. 2011. 37: 24–39.
36. Galea, I., Bernardes-Silva, M., Forse, P. A., van Rooijen, N., Liblau, R. S., Perry, V. H., An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J. Exp. Med. 2007. 204: 2023–2030.
37. Denic, A., Wootla, B., Rodriguez, M., CD8 +T cells in multiple sclerosis. Expert Opin. Ther. Targets 2013. 17: 1053–1066.
38. Codarri, L., Greter, M., Becher, B., Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease. Trends Immunol. 2013. 34: 114–119.
39. Cao, Y., Toben, C., Na, S.-Y., Stark, K., Nitschke, L., Peterson, A., Gold, R. et al., Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes. Eur. J. Immunol. 2006. 36: 207–215.
40. Saxena, A., Bauer, J., Scheikl, T., Zappulla, J., Audebert, M., Desbois, S., Waisman, A. et al., Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J. Immunol. 2008. 181: 1617–1621.
41. Morgan, D. J., Liblau, R., Scott, B., Fleck, S., McDevitt, H. O., Sarvetnick, N., Lo, D. et al., CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 1996. 157: 978–983.
42. + T cells. Immunity 2012. 37: 134–146.
43. Martin-Blondel, G., Pignolet, B., Tietz, S., Yshii, L., Gebauer, C., Perinat, T., Van Weddingen, I. et al., Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the α4β1-integrin. Eur. J. Immunol. 2015. 45: 3302–3312
44. Hogg, N., Patzak, I., Willenbrock, F., The insider's guide to leukocyteintegrin signalling and function. Nat. Rev. Immunol. 2011. 11: 416–426.
45. Shulman, Z., Shinder, V., Klein, E., Grabovsky, V., Yeger, O., Geron, E., Montresor, A. et al., Lymphocyte Crawling and Transendothelial Migration Require Chemokine Triggering of High-Affinity LFA-1 Integrin. Immunity 2009. 30: 384–396.
46. Lek, S. H., Morrison, V. L., Conneely, M., Campbell, P. A., McGloin, D., Kliche, S., Watts, C. et al., The spontaneously adhesive leukocyte function-associated antigen-1 (LFA-1) integrin in effector T cells mediates rapid actin- and calmodulin-dependent adhesion strengthening to ligand under shear flow. J. Biol. Chem. 2013. 288: 14698–14708.
47. Evans, R., Lellouch, A. C., Svensson, L., McDowall, A., Hogg, N., The integrin LFA-1 signals through ZAP-70 to regulate expression of high-affinity LFA-1 on T lymphocytes. Blood 2011. 117: 3331–3341.
48. Schnoor, M., Endothelial actin-binding proteins and actin dynamics in leukocyte transendothelial migration. J. Immunol. 2015. 194: 3535–3541.
49. Lyck, R., T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells. Blood 2003. 102: 3675–3683.
50. Bullard, D. C., Hu, X., Schoeb, T. R., Collins, R. G., Beaudet, A. L., Barnum, S. R., Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis. J. Immunol. 2007. 178: 851–857.
51. Gerwin, N., Gonzalo, J.-A., Lloyd, C., Coyle, A. J., Reiss, Y., Banu, N., Wang, B. et al., Prolonged eosinophil accumulation in allergic lung interstitium of ICAM-2-deficient mice results in extended hyperresponsiveness. Immunity 1999. 10: 9–19.
52. Winderlich, M., Keller, L., Cagna, G., Broermann, A., Kamenyeva, O., Kiefer, F., Deutsch, U. et al., VE-PTP controls blood vessel development by balancing Tie-2 activity. J. Cell Biol. 2009. 185: 657–671.
53. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., Carbone, F. R., T cell receptor antagonist peptides induce positive selection. Cell 1994. 76: 17–27.
54. Barnden, M., Allison, J., Heath, W. R., Carbone, F. R., Defective TCR expression in transgenic mice constructed using cDNA-based a- and b-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 1998. 76: 34–40.
55. Engelhardt, B., Kempe, B., Merfeld-Clauss, S., Laschinger, M., Furie, B., Wild, M. K., Vestweber, D., P-Selectin Glycoprotein Ligand 1 Is Not Required for the Development of Experimental Autoimmune Encephalomyelitis in SJL and C57BL/6 Mice. J. Immunol. 2005. 175: 1267–1275.
56. Engelhardt, B., Laschinger, M., Schulz, M., Samulowitz, U., Vestweber, D., Hoch, G., The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. J. Clin. Invest. 1998. 102: 2096–2105.
57. Döring, A., Wild, M., Vestweber, D., deutsch, U., Engelhardt, B., E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J. Immunol. 2007. 179: 8470–8479.
58. Sathiyanadan, K., Coisne, C., Enzmann, G., deutsch, U., Engelhardt, B., PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE. Eur. J. Immunol. 2014. 44: 2287–2294.
59. Coisne, C., Dehouck, L., Faveeuw, C., Delplace, Y., Miller, F., Landry, C., Morissette, C. et al., Mouse syngenic in vitro blood–brain barrier model: a new tool to examine inflammatory events in cerebral endothelium. Lab. Invest. 2005. 85: 734–746.
60. Carbone, F. R., Sterry, S. J., Butler, J., Rodda, S., Moore, M. W., T cell receptor alpha-chain pairing determines the specificity of residue 262 within the Kb-restricted, ovalbumin257-264 determinant. Int. Immunol. 1992. 4: 861–867.
61. Engelhardt, B., Vestweber, D., Hallmann, R., Schulz, M., E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood 1997. 90: 4459–4472.
62. Laschinger, M., Engelhardt, B., Interaction of alpha4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. J. Neuroimmunol. 2000. 102: 32–43.
63. Lefort, C. T., Rossaint, J., Moser, M., Petrich, B. G., Zarbock, A., Monkley, S. J., Critchley, D. R. et al., Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation. Blood 2012. 119: 4275–4282.